Watchlist
MXL · MaxLinear, Inc.
Last analysed ·
Against its published line
Nothing is through its line on this close.
How to read this
The red mark is the published kill line — the price that would prove the pick wrong. The dot is where the name closed on 18 September 2026; a dot LEFT of the mark has closed through its line.
Distance is drawn on a square-root scale, so close calls get the room. Past 8% a row stops competing and reads well clear, with a hollow dot to say the figure is off the drawn scale. Rows run tightest first.
Resolved Graded and closed 2026-09-18 at low conviction — the published kill line did not fire. Coverage continued after the close; the read below is dated 2026-09-19 and is not part of the scored record.
Current thesis
The AI-optical revenue leg still compounds — Q3 guided to $210–220M against Q2's $168.8M — while the price leg makes new lows: the 2026-09-04 close of $62.74 is 51.0% below the $128.03 high with RSI(14) at 25.1, after roughly $50M of Seendripu-trust stock was sold or filed for sale on 2026-08-14/17. Nothing company-dated resolves before the ~2026-10-22 print; the 2026-09-09 Citi slot is the last scheduled webcast.
Kill line
A weekly close below $62 puts price under the entire post-Q2-print range including the $67 early-August area, marking a trending decline rather than a base; secondary break is the 2026-09-09 Citi and 2026-09-10 StoneX slots passing with no update to the $210–230M 2026 optical range, or Q3 revenue landing inside rather than above the $210–220M guide.
Pick status
Played out resolved published kill line did not fire How this is scored →Latest analysis and events for MXL —
As of 20 September 2026, the latest FrontierPicks analysis for MaxLinear, Inc. (MXL): The AI-optical revenue leg still compounds — Q3 guided to $210–220M against Q2's $168.8M — while the price leg makes new lows: the 2026-09-04 close of $62.74 is 51.0% below the $128.03 high with RSI(14) at 25.1, after roughly $50M of Seendripu-trust stock was sold or filed for sale on 2026-08-14/17. Nothing company-dated resolves before the ~2026-10-22 print; the 2026-09-09 Citi slot is the last scheduled webcast.
Kill line: A weekly close below $62 puts price under the entire post-Q2-print range including the $67 early-August area, marking a trending decline rather than a base; secondary break is the 2026-09-09 Citi and 2026-09-10 StoneX slots passing with no update to the $210–230M 2026 optical range, or Q3 revenue landing inside rather than above the $210–220M guide.
Current Thesis
MaxLinear’s artificial-intelligence optical-chip story now has a price recovery behind it; Q3 revenue above the company’s $220 million guidance ceiling would confirm renewed acceleration, while a weekly close below $77 would break the recovered July shelf. The 2026-09-18 adjusted close of $81.12 is above that shelf, reversing the structural weakness described on 2026-09-05. This refresh tests whether that recovery survives through the next results announcement.
The operating evidence remains the 2026-07-23 results: Q2 revenue of $168.8 million, infrastructure revenue growth of 145% year over year, and Q3 revenue guidance of $210–220 million. Management also raised its 2026 optical data-center revenue expectation to $210–230 million. Those are reported results and management forecasts respectively; the inference is that optical growth can support the recovered price structure.
The narrative is maturing — the July guidance remains the operating anchor, Benzinga repeated its historical-return coverage on 2026-08-26 and 2026-09-08, and the September 18 close has recovered the previously broken shelf. This replaces the September 5 saturation assessment because price has recovered, although broader participation is unmeasured. A weekly close below $77 would invalidate that rehabilitation.
Bullish and bearish views on MaxLinear, Inc.
The model's bull view on MaxLinear, Inc. (MXL), in brief: Reported growth supports the story. MaxLinear’s 2026-07-23 release reported Q2 revenue of $168.8 million, up 55% year over year and 23% sequentially. Infrastructure became the largest revenue category, providing operating evidence for the optical-infrastructure supplier thesis.… The bear view: The longer decline remains visible. At the 2026-09-18 close, the shares remained 36.6% below their $128.03 trailing-year high and were down 15.9% over three months. Recovery above a former shelf does not establish a sustained uptrend. Insider supply remains documented. The CEO’s… Both cases follow in full.
Bull Case
- Reported growth supports the story. MaxLinear’s 2026-07-23 release reported Q2 revenue of $168.8 million, up 55% year over year and 23% sequentially. Infrastructure became the largest revenue category, providing operating evidence for the optical-infrastructure supplier thesis.
- Guidance requires another revenue step. The 2026-07-23 Q3 outlook called for $210–220 million of revenue and a non-GAAP gross margin of 58.5%–61.5%. Revenue above the upper bound at the next report is the confirmation condition for this refresh.
- Price has recovered lost structure. The adjusted close increased from $62.74 on 2026-09-04 to $81.12 on 2026-09-18. The latter is above the $77 July shelf identified in the September 5 public note; a weekly close below $77 would defeat this recovery interpretation.
Bear Case
- The longer decline remains visible. At the 2026-09-18 close, the shares remained 36.6% below their $128.03 trailing-year high and were down 15.9% over three months. Recovery above a former shelf does not establish a sustained uptrend.
- Insider supply remains documented. The CEO’s 2026-08-17 Form 144 disclosed completed trust sales on August 14 and a further proposed sale; a Form 4 followed on August 18. The proposed transaction is not evidence that every contemplated sale occurred, and these filings cannot establish the cause of September price movements.
- Analyst attention is not an upgrade. Stock Analysis lists StoneX reiterating its $125 analyst target on 2026-09-14 and an average target of $94.55 across 11 analysts as of September 19. The listed reiteration supplies no new company revenue forecast. Stock Analysis analyst table
Setup & Price Structure
The measured change is a recovery above the historical $77 shelf at the 2026-09-18 close of $81.12. The 14-period relative strength index rose from 25.1 on September 4 to 68.3 on September 18. Neither observation measures ownership concentration or establishes that the rebound has formed a durable base.
The revised weekly-close threshold is $77 because this refresh evaluates the recovered July structure. The September 5 note used $62 for a different, deeper breakdown condition; the available endpoint closes do not establish whether that earlier condition fired between observations.
Benzinga’s August 26 and September 8 historical-return articles show repeated retail-facing coverage. That sample is too small to support a crowding claim. Current moving-average distances, turnover, short interest and fund-flow measurements are missing, so expanding participation cannot be inferred from the price recovery alone.
Catalyst Calendar (next 30 days)
- 2026-09-30 — Q3 quarter end. This closes the reporting period covered by the $210–220 million revenue guidance issued on July 23. Quarter end itself is not a scheduled results disclosure.
- ~2026-10-22, estimated — Q3 results. This falls beyond the next 30 days but is the event on which the operating thesis turns. MarketBeat identifies the date as estimated and unconfirmed; the report tests revenue against the $220 million guidance ceiling and management’s $210–230 million annual optical outlook. MarketBeat earnings calendar
No confirmed thesis-resolving disclosure within the next 30 days was established as of 2026-09-19. The September 9 Citi and September 10 StoneX appearances are elapsed; their passage alone does not establish whether management changed its outlook.
What Would Change Our Mind
Loss of the recovered July shelf would end the price-recovery thesis: a weekly close below $77 is the observable break. Operating confirmation requires Q3 revenue above $220 million at the next report, with the 2026 optical outlook maintained or raised from the $210–230 million range announced July 23. Revenue within the original Q3 range would meet guidance but fail this refresh’s stronger acceleration test.
The evidence supports medium conviction: the September 18 close repairs a previously broken level, while the next operating test remains outstanding. A Q3 non-GAAP gross margin below the July 23 guidance floor of 58.5% would also undermine the case that the revenue expansion is translating into the guided profitability.
Correlation Notes
This remains a single-name setup: the September 19 coverage context identifies no active theme cluster containing MaxLinear. Its optical-infrastructure exposure is supported by the 145% infrastructure revenue growth reported on July 23, but that business connection is not a measured stock-return correlation.
The September 14 Corning headline concerns another issuer’s offering and does not establish a change in MaxLinear demand. No paired return series is available to distinguish optical-sector participation from company-specific recovery.
Notes
- Silicon Motion SIAC arbitration (filed October 2023) over the terminated 2022 merger is confidential; the claim is the $160M termination fee plus unspecified further damages, interest and costs.
- Cash and equivalents were $64.8M at 2026-06-30, small relative to that claim; no litigation reserve figure is disclosed in the Q2 2026 release.
- GAAP and non-GAAP results diverge widely: Q2 2026 GAAP EPS $0.02 vs non-GAAP $0.35, on stock compensation and acquisition/integration items.
- Fiscal year is the calendar year. Q3 FY26 ends 2026-09-30 and the print has historically followed roughly three weeks later; the company has not confirmed a date.
- Form 144 filings signal intent to sell within three months, not completed sales; execution is confirmed only against the matching Form 4.
- The theme registry carries no active cluster for this name as of 2026-09-05, so a group-move argument has no current support.
Related · shared themes
QRVO
Qorvo, Inc.
Qorvo trades as a fixed-ratio merger spread: 0.960 SWKS plus $32.50 cash. Skyworks' $74.02 close on 2026-09-04 implies $103.56 against Qorvo's $102.84 — about 0.70% gross, the thinnest of this coverage, after the acquirer rallied 12.5% in a week. The completion story is saturated: both legs trade above the ~2026-07-29 sell-side targets and SAMR still carries no announced decision date.
SMTC
Semtech Corporation
The mix-purification leg has lost its price leg: the August bounce round-tripped from a $140.35 close on 2026-08-14 to $124.09 on 2026-08-21, under the 2026-07-17 flush close. The binary moved forward — Q2 FY27 prints 2026-08-25 after the close, with consensus ($328.4M / $0.62) sitting exactly on the guide, so the October outlook carries the move.
ADI
Analog Devices, Inc.
Analog Devices’ AI and industrial growth story supports a recovery thesis, with fourth-quarter delivery as the operating test. Revenue at or above the $4.3 billion guidance midpoint and a daily close above the supplied $444.13 annual high would satisfy the case before a weekly close below $345 invalidates it.
HIMX
Himax Technologies, Inc.
Himax Technologies' AI-sensing re-rating requires a named, shipping smart-glasses product and Q3 revenue meeting its August 6 guidance before a weekly close below $13. The September 11 reclaim of the post-earnings reference close improves structure, while commercialization remains unproven.
See also · stocks to watch